Published • loading... • Updated
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit
Rosen Law Firm says investors may seek lead plaintiff status as the suit alleges Medpace hid backlog cancellation risks and offered inflated growth expectations.
- Rosen Law Firm reminds purchasers of Medpace Holdings, Inc. common stock between April 22, 2025, and February 9, 2026, of the June 8, 2026, lead plaintiff deadline for the pending securities class action lawsuit.
- The complaint alleges Medpace Holdings, Inc. made materially false and misleading statements about its backlog cancellation rates, touting "well behaved" rates while concealing adverse facts that resulted in significant investor damages.
- With a track record of success, Rosen Law Firm has recovered hundreds of millions of dollars for investors and consistently ranked in the top four firms for securities class action settlements since 2013.
- Joining the class action allows investors to seek potential recovery without paying out-of-pocket costs, as the firm operates on a contingency fee basis and asks the court to reimburse expenses only if successful.
- Shareholders may choose to remain absent class members with no requirement to participate to share in potential recovery, though they must move the court by the June 8, 2026, deadline to serve as lead plaintiff.
Insights by Ground AI
50 Articles
50 Articles
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the ...
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (NASDAQ: GOSS ) for violations of §§10(b)…
·Nebraska, United States
Read Full Article
ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit with the Schall ...
LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alight, Inc. (“Alight” or “the Company”) (NYSE: ALIT ) for violations of §§10(b) and…
Coverage Details
Total News Sources50
Leaning Left7Leaning Right5Center17Last UpdatedBias Distribution59% Center
Bias Distribution
- 59% of the sources are Center
59% Center
L 24%
C 59%
R 17%
Factuality
To view factuality data please Upgrade to Premium
